Trials / Completed
CompletedNCT01660256
Confirmatory Study of OPC-12759 Ophthalmic Solution
Confirmatory Study of OPC-12759 Ophthalmic Solution in Patients With Dry Eye
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 209 (actual)
- Sponsor
- Otsuka Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to verify whether OPC-12759 ophthalmic solution is effective compared with placebo in dry eye patients. OPC-12759 ophthalmic suspension will be used as a reference drug.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | OPC-12759 | Instillation, 4 times/day for 4 weeks |
| DRUG | Placebo |
Timeline
- Start date
- 2012-08-01
- Primary completion
- 2013-03-01
- Completion
- 2013-05-01
- First posted
- 2012-08-08
- Last updated
- 2021-05-05
- Results posted
- 2021-05-05
Locations
4 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01660256. Inclusion in this directory is not an endorsement.